We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NI:NYSENiSource Inc Analysis

Data as of 2026-06-12 - not real-time

$46.62

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

NiSource is trading just below its 20‑day moving average and marginally under its 50‑day average, with a neutral RSI around 49 and a bullish MACD histogram suggesting modest upside momentum. The stock’s current price sits near the identified support level of $45.09 and well below the short‑term resistance of $48.05, while volatility over the past 30 days is elevated at roughly 18%, though beta remains low, indicating limited market‑wide risk. Fundamentally, the company posted an 8% revenue increase and a solid operating margin above 34%, but its free cash flow is negative and debt‑to‑equity exceeds 140%, flagging balance‑sheet pressure.
Analysts have reaffirmed earnings guidance and lifted long‑term growth expectations, buoyed by a new data‑center strategy and a fresh $0.30 dividend, yielding about 2.6% with a payout ratio under 60%, which supports dividend sustainability. However, the forward PE of 23 is above the industry average of 20 and the DCF‑derived fair value of $22 is far below the market price, suggesting the stock is overvalued despite its regulated utility stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bullish MACD signal
  • Stable dividend yield of 2.6%
  • Neutral RSI indicating limited upside/downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Management raised long‑term growth outlook
  • Regulated earnings provide predictable cash flow
  • Attractive dividend payout relative to peers

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage and negative free cash flow
  • Significant valuation gap to DCF fair value
  • Sustained regulatory environment supporting cash stability

Key Metrics & Analysis

Financial Health

Revenue Growth8.20%
Profit Margin14.10%
P/E Ratio23.2
ROE9.11%
ROA3.39%
Debt/Equity140.91
P/B Ratio2.3
Op. Cash Flow$2.1B
Free Cash Flow$-1562412544
Industry P/E20.3

Technical Analysis

TrendNeutral
RSI49.3
Support$45.09
Resistance$48.05
MA 20$46.65
MA 50$47.25
MA 200$44.39
MACDBullish
VolumeStable
Fear & Greed Index87.54

Valuation

Fair Value$22.26
Target Price$51.36
Upside/Downside10.16%
GradeOvervalued
TypeBlend
Dividend Yield2.57%

Risk Assessment

Beta0.19
Volatility18.14%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.